![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2016-06-24 Purchase | 2016-06-28 4:41 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CFO COO | 5,300 | $6.2151 | $32,940 | 4,300 (Indirect Direct) | View |
2017-08-10 Purchase | 2017-08-14 6:07 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CFO COO | 15,000 | $2.8817 | $43,225 | 14,300 (Indirect Direct) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2017-03-13 Option Award | 2017-03-14 4:26 pm | N/A 2027-03-12 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CFO COO | 75,000 | $0 | 75,000 (Direct) | View |
2017-10-23 Option Award | 2017-10-24 6:48 pm | N/A 2027-10-22 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CFO COO | 25,000 | $0 | 25,000 (Direct) | View |
2018-03-12 Option Award | 2018-03-13 5:42 pm | N/A 2028-03-11 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CFO | 105,000 | $0 | 105,000 (Direct) | View |
2019-09-16 Option Award | 2019-09-18 6:47 pm | N/A 2029-09-15 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CFO | 135,000 | $0 | 135,000 (Direct) | View |
2020-03-12 Option Award | 2020-03-13 5:03 pm | N/A 2030-03-11 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CFO | 145,000 | $0 | 145,000 (Direct) | View |
2021-03-12 Option Award | 2021-03-15 4:37 pm | N/A 2031-03-11 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CFO | 100,000 | $0 | 100,000 (Direct) | View |